drugset / Trial / NCT04320745

A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants

NCT04320745

Phase 4 Completed 168 enrolled Allergan
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the effect of a once daily Androderm® dose on Blood Pressure (BP) in adult hypogonadal men as measured by 24-hour ABPM.

Timeline

Start
2020-05-19
Primary completion
2021-06-24
Completion
2021-06-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 2 mg Other
Subject Testosterone Small molecule 4 mg Other
Subject Testosterone Small molecule 6 mg Other

Indications